Journal profile · Clinical Neurology
Epilepsia
ISSN 0013-9580 · eISSN 1528-1167 · Wiley-Blackwell Publishing Ltd · UNITED STATES · Monthly · Founded 1909
Epilepsia: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 5.51; hybrid open access; APC about USD 4,360; median 95 days to acceptance (120 articles, last 24 months); community-reported acceptance: fairly hard; 559 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Epilepsia is published by Wiley-Blackwell Publishing Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies and Neuroscience and Neuropharmacology Research, together about 61.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
<em>Epilepsia</em> is the leading journal for innovative clinical and basic science research for all aspects of epilepsy and seizures, aiming to improve diagnosis and treatment.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Epilepsy research and treatmentMedicine35.1%
- Pharmacological Effects and Toxicity StudiesMedicine13.7%
- Neuroscience and Neuropharmacology ResearchNeuroscience12.5%
- EEG and Brain-Computer InterfacesNeuroscience4.8%
- Neurological disorders and treatmentsMedicine3.3%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology3.2%
- Psychosomatic Disorders and Their TreatmentsMedicine2.9%
- Functional Brain Connectivity StudiesNeuroscience2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.51LetPub ·
- Impact factor (publisher)
- 5.6Publisher website ·
- CiteScore 2026-06
- 11.2LetPub ·
- CiteScore (publisher)
- 11.2Publisher website ·
- SJR 2026-06
- 2.2LetPub ·
- SNIP 2026-06
- 2.53LetPub ·
- h-index
- 174LetPub ·
- h-index
- 287OpenAlex ·
- i10-index
- 11,275OpenAlex ·
- 2-year mean citedness
- 4.77OpenAlex ·
- Self-citation rate
- 12.5%LetPub ·
- Share of gold OA articles
- 52.93%LetPub ·
Volume
- Articles per year
- 463LetPub ·
- Downloads per year (publisher)
- 2,500,000Publisher website ·
Articles by year OpenAlex count · 18,333 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 437 | 340 | 214 |
| 2025 | 559 | 425 | 2,713 |
| 2024 | 390 | 318 | 3,680 |
| 2023 | 408 | 337 | 6,175 |
| 2022 | 357 | 239 | 11,789 |
| 2021 | 378 | 208 | 10,676 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
95 daysMedian, submission to acceptance · P25–P75 72 days – 121 days
- Acceptance to online
- median 18 days (122 articles)
- Submission to online
- median 116 days
- Sample
- 120 articles with submission and acceptance dates (1,081 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 2–4 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Acceptance rate (publisher)
- 27%Publisher website ·
- Submission to first decision
- 13 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,360 / EUR 3,640 / GBP 2,920 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1909
- ISSN
- 0013-9580
- Electronic ISSN
- 1528-1167
- Society / sponsor
- International League Against Epilepsy
- Latest issue on the website
- Volume 67, Issue 8 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Epilepsia
What CAS zone is Epilepsia in?
In the 2025 upgraded edition of the CAS Journal Ranking, Epilepsia is in Zone 1 of Medicine, and in Zone 1 of the minor category Clinical Neurology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Epilepsia?
The latest impact factor listed by LetPub is 5.51; CiteScore 11.2, h-index 287.
How long does peer review take at Epilepsia?
Based on the dates recorded on 120 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 72–121 days); authors report an average review time of 2–4 weeks; the community-reported acceptance is “Fairly hard”; the journal's website gives an acceptance rate of 27%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Epilepsia?
According to LetPub and DOAJ records, Epilepsia is indexed in SCIE and Scopus.
Is Epilepsia open access, and what is the APC?
Epilepsia is a hybrid journal. For open-access publication: APC about USD 4,360.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .